Keywords: ec, expands, indication, roche, avastin, european, commission

EC expands indication for Roche's Avastin

Article | 09 April 2007

Print This

The European Commission has approved Swiss drug major Roche's Avastin (bevacizumab) for the first line treatment of women with metastatic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in